A saliva-based test for breast cancer might be near
August 4, 2025
In a small new study, a handheld saliva-sampling device successfully detected breast cancer 100% of the time, researchers said.
In a small new study, a handheld saliva-sampling device successfully detected breast cancer 100% of the time, researchers said.
Using a custom-built tool to analyze the electrical activity from neurons, researchers at Brown University have identified a brain-based biomarker that could be used to predict whether mild cognitive impairment will develop into Alzheimer’s disease.
New research has uncovered a novel mechanism that may help explain why some people with cancer respond remarkably well to immunotherapy while others don’t.
University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a “two-in-one” molecule that can simultaneously turn off two notoriously difficult-to-target cancer-related genes, KRAS and MYC, as well as directly deliver drugs to tumors that express these genes. This advance holds special promise for treating cancers that have been historically challenging to treat.
About one quarter of patients with muscle-invasive bladder cancer (MIBC) may be treated and derive a benefit with the current standard chemotherapy. To better understand why some tumors resist chemotherapy and identify better ways to treat those cancers, researchers at Baylor College of Medicine have conducted a detailed molecular analysis of MIBC tumors.
A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive tracking and optimized treatment for diabetic patients.
Researchers have developed a powerful new tool that makes it easier to study the mix of cell types in human tissue, which is crucial for understanding diseases such as cancer.
TWINSBURG, Ohio, July 15, 2025 /PRNewswire/ — Edgepark has recently expanded its portfolio to include the latest innovations from diabetes manufacturers, including the first-ever FDA-cleared yearlong continuous glucose monitor (CGM) system, and a glucose biosensor that can be purchased without a prescription.
CLEVELAND, July 15, 2025 /PRNewswire/ — IdentifySensors Biologics, a leader in digital diagnostic technologies, has demonstrated that its electronic biosensors used to detect pathogens can also detect cancer cells.
The new implant carries a reservoir of glucagon that can be stored under the skin and deployed during an emergency — with no injections needed.